DrugPatentWatch Database Preview
Patent: 5,028,439
Summary for Patent: 5,028,439
| Title: | Inhibition of parathyroid hormone secretion |
| Abstract: | Parathyroid Hormone, when excessively synthesized, induces pathologic bone resorption and demineralization and results in hypocalcemia which produces toxic effects in soft tissues. Non-toxic water-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid, administered orally or systemically, inhibits parathyroid hormone induced bone resorption in vitro and in vivo in warm blooded animals. |
| Inventor(s): | Gaffar; Abdul (Somerset, NJ) |
| Assignee: | Colgate Palmolive Company (Piscataway, NJ) |
| Application Number: | 07/296,390 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,028,439
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Colgate Palmolive Company (Piscataway, NJ) | 2008-07-02 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | Colgate Palmolive Company (Piscataway, NJ) | 2008-07-02 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | Colgate Palmolive Company (Piscataway, NJ) | 2008-07-02 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Colgate Palmolive Company (Piscataway, NJ) | 2008-07-02 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
